Enoxaparin Sodium Injection
Product Images NDC 63323-564

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 63323-564). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eno0b 0002 01

An instructional illustration showing hands disconnecting two parts of a syringe-like injection device, with a double-headed arrow indicating separation. The image likely depicts a step involved in preparing a subcutaneous injection of Enoxaparin Sodium.*

FDA Label Image

Eno0b 0002 02

An instructional diagram labeled 'Figure B' showing a hand holding an injection pen or syringe with an arrow indicating the direction of use or injection, related to administering Enoxaparin Sodium subcutaneously.*

FDA Label Image

Eno0b 0002 03

An instructional illustration showing a hand manipulating the cap of a vial or syringe, indicated by arrows demonstrating the direction of movement. The image is labeled as Figure C, suggesting it is part of a step-by-step usage guide for Enoxaparin Sodium injection by Fresenius Kabi USA, LLC.*

FDA Label Image

Eno0b 0002 04

Illustration showing a hand holding a syringe with the needle pointing upwards and an arrow indicating the removal of a cap or cover from the syringe tip, associated with Enoxaparin Sodium injection preparation or administration.*

FDA Label Image

Eno0b 0002 05

An instructional diagram showing a hand disposing of a syringe into a container labeled "BIOHAZARD," indicating proper disposal of used injection needles or syringes.*

FDA Label Image

Eno0b 0002 06

Chemical structure diagram of Enoxaparin Sodium, showing repeated disaccharide units with sodium salts and various substituents indicated as R groups.*

FDA Label Image

Eno0b 0002 07

Chemical structure diagram of Enoxaparin Sodium, illustrating the molecular composition with various functional groups and substituents depicted.*

FDA Label Image

Eno0b 0002 08

A forest plot chart illustrating the relative risk comparison between Enoxaparin Sodium and Unfractionated Heparin (UFH) across various patient subgroups and conditions. The chart shows dots representing relative risk values for each subgroup, with confidence intervals, and comparative percentages for UFH and Enoxaparin alongside reduction in risk percentages. The plot visually summarizes risk reduction outcomes favoring Enoxaparin in most subgroups.*

FDA Label Image

Eno0b 0002 09

A Kaplan-Meier plot showing the hazard distribution function over time to death or myocardial re-infarction (days) comparing Enoxaparin and UFH (unfractionated heparin). The main plot spans 30 days, with Enoxaparin showing a lower hazard than UFH. A smaller inset plot extends to one year, also comparing the two treatments. The graph includes log-rank test p-values indicating statistical differences.*

FDA Label Image

Eno0b 0002 10

Enoxaparin Sodium injection carton by Fresenius Kabi USA, LLC. The packaging displays multiple available strengths, including 100 mg/mL, 120 mg/.8mL, 150 mg/mL, 30 mg/.3mL, 40 mg/.4mL, 60 mg/.6mL, and 80 mg/.8mL. The label includes the proprietary and nonproprietary name, dosage form, route (subcutaneous), and the labeler information. The box is white with blue and black text.*

FDA Label Image

Eno0b 0002 11

Packaging label for Enoxaparin Sodium Injection, USP 30 mg per 0.3 mL by Fresenius Kabi USA, LLC. The label indicates single-dose syringes with automatic safety device for subcutaneous injection. The package contains 10 x 0.3 mL single-dose syringes and includes directions for use, warnings, and manufacturer information.*

FDA Label Image

Eno0b 0002 12

Label for Enoxaparin Sodium Injection USP with a strength of 30 mg per 0.3 mL in a sterile single-dose syringe with an automatic safety device, intended for subcutaneous injection. The product is manufactured for Fresenius Kabi USA, LLC. The label includes storage and dosage instructions and a barcode.*

FDA Label Image

Eno0b 0002 13

Packaging label for Enoxaparin Sodium Injection, USP 40 mg per 0.4 mL by Fresenius Kabi USA, LLC. The label indicates this is a prescription subcutaneous injection available as single-dose syringes with an automatic safety device. The package contains 10 syringes of 0.4 mL each. Instructions for use with illustrations and storage warnings are also visible.*

FDA Label Image

Eno0b 0002 14

Enoxaparin Sodium 40 mg per 0.4 mL injection label shows a sterile single-dose syringe with an automatic safety device for subcutaneous use. The label includes dosing instructions, storage conditions (20° to 25°C), manufacturer Fresenius Kabi USA, LLC, and indicates the product is made in India. A barcode is also visible.*

FDA Label Image

Eno0b 0002 15

Packaging label for Enoxaparin Sodium Injection, USP, 60 mg per 0.6 mL. The product is supplied by Fresenius Kabi USA, LLC in single-dose syringes with automatic safety devices for subcutaneous injection. The carton features instructions for use and contains 10 syringes of 0.6 mL each. Barcodes and the NDC 63323-566-98 are visible.*

FDA Label Image

Eno0b 0002 16

Enoxaparin Sodium Injection, USP 60 mg per 0.6 mL in a sterile single-dose syringe with automatic safety device for subcutaneous injection. The label indicates the dosage strength, volume, manufacturer Fresenius Kabi USA, LLC, storage instructions at 20° to 25°C, and a barcode. It also includes a warning to keep out of reach of children and specifies it is for prescription use only.*

FDA Label Image

Eno0b 0002 17

Packaging label for Enoxaparin Sodium Injection, USP 80 mg per 0.8 mL, a subcutaneous injection by Fresenius Kabi USA, LLC. The label indicates single-dose syringes with automatic safety devices, containing 10 x 0.8 mL syringes. It includes directions for use illustrations, barcodes, and safety notes.*

FDA Label Image

Eno0b 0002 18

Label for Enoxaparin Sodium Injection, USP 80 mg per 0.8 mL in a sterile single-dose syringe with automatic safety device. The label includes dosage form as injection for subcutaneous use. Manufacturer is Fresenius Kabi USA, LLC, with storage instructions and a barcode.*

FDA Label Image

Eno0b 0002 19

Packaging label for Enoxaparin Sodium Injection, USP 100 mg per mL by Fresenius Kabi USA, LLC. The label indicates that the drug is for subcutaneous injection and includes 10 x 1 mL single-dose syringes with automatic safety devices. Directions for use with the safety device are illustrated on the label. The label also includes barcode and regulatory information.*

FDA Label Image

Eno0b 0002 20

Label for Enoxaparin Sodium Injection USP 100 mg per mL in a 1 mL sterile single-dose syringe with automatic safety device for subcutaneous injection. Manufactured by Fresenius Kabi USA, LLC, the label includes dosage information, storage instructions, a barcode, and states the product is Rx only.*

FDA Label Image

Eno0b 0002 21

Packaging label for Enoxaparin Sodium Injection, USP 120 mg per 0.8 mL by Fresenius Kabi USA, LLC. The label indicates it is a subcutaneous injection available as single-dose syringes with an automatic safety device. The package contains 10 syringes of 0.8 mL each. Directions for use and barcode are visible, along with storage instructions and Rx only designation.*

FDA Label Image

Eno0b 0002 22

Label for Enoxaparin Sodium Injection USP 120 mg per 0.8 mL in a sterile single-dose syringe with automatic safety device. The label indicates subcutaneous injection use, storage instructions at 20° to 25°C, dosage and administration notes, and that the product is manufactured for Fresenius Kabi USA, LLC. It also includes a barcode and manufacturing details.*

FDA Label Image

Eno0b 0002 23

Packaging label for Enoxaparin Sodium Injection, USP 150 mg per mL by Fresenius Kabi USA, LLC. The label indicates the product includes single-dose syringes with an automatic safety device for subcutaneous injection. The package contains 10 syringes of 1 mL each. Directions for use and barcode are also shown on the label in a blue and white color scheme with dark blue grid background detailing the product information and warnings.*

FDA Label Image

Eno0b 0002 24

Label for Enoxaparin Sodium Injection, USP, 150 mg per mL in a 1 mL sterile single-dose syringe with automatic safety device for subcutaneous injection. Manufactured for Fresenius Kabi USA, LLC, with storage instructions and a barcode visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.